Personalized Medicine and Proteomics: Lessons from Non-Small Cell Lung Cancer

This publication has 51 references indexed in Scilit:

• Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
  The Lancet, 2005
• IncreasedHER2Gene Copy Number Is Associated With Response to Gefitinib Therapy in Epidermal Growth Factor Receptor–Positive Non–Small-Cell Lung Cancer Patients
  Journal of Clinical Oncology, 2005
• Efficacy of the tyrosine kinase inhibitor gefitinib in a patient with metastatic small cell lung cancer
  Lung Cancer, 2005
• Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
  JNCI Journal of the National Cancer Institute, 2005
• The epidemiology of interstitial lung disease and its association with lung cancer
  British Journal of Cancer, 2004
• Regulation of an ATG7 - beclin 1 Program of Autophagic Cell Death by Caspase-8
  Science, 2004
• Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
  New England Journal of Medicine, 2004
• Lung Cancer and Cryptogenic Fibrosing Alveolitis
  American Journal of Respiratory and Critical Care Medicine, 2000
• Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis.
  American Journal of Respiratory and Critical Care Medicine, 1997
• Iung cancer associated with usual interstitial pneumonia
  Pathology International, 1995